EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

L-Borneolum Attenuates Ischemic Stroke Through Remodeling BBB Transporter Function via Regulating MFSD2A/Cav-1 Signaling Pathway

L-Borneolum mildert ischämischen Schlaganfall durch Umbau der BBB-Transportfunktion über den MFSD2A/Cav-1-Signalweg

Peiru Wang, Yilun Ma iD, Dazhong Lu, Li Wen, Fengyu Huang, Jianing Lian, Mengmeng Zhang, Taiwei Dong

Brain Sciences · 20.01.2026 · 16 (1) · 111

DOI: 10.3390/brainsci16010111 ↗

Auf einen Blick

Im Rattenmodell des MCAO/R verbesserte L-Borneolum sowie L-borneol/L-camphor die neurologischen Befunde und die Blut-Hirn-Schranke. Die Effekte waren mit Veränderungen von MFSD2A und Cav-1 verbunden.

Fragestellung

Verglichen die Autoren die neuroprotektiven Effekte von L-Borneolum und seiner Hauptkomponenten im Rattenmodell des ischämischen Schlaganfalls?

Methode

Rattenmodell MCAO/R; Behandlung mit L-Borneolum 200 mg/kg oder L-borneol/L-camphor 6:4, 200 mg/kg. Bewertung mit neurologischen Scores, TTC, HE, Nissl, Doppler, Albuminleckage, TEM, MTT, TEER, HRP, RT-qPCR und Western Blot.

Ergebnisse

Beide Behandlungen senkten neurologische Scores und Infarktfläche, verbesserten die zerebrale Durchblutung, reduzierten Albuminleckage und Vesikelzahl und erhöhten Nissl-Körperchen. SREBP1 und MFSD2A stiegen, Cav-1 sank gegenüber dem Modell.

Schlussfolgerung der Autor:innen

L-Borneolum und die Kombination L-borneol/L-camphor könnten bei Ratten mit ischämischem Schlaganfall protektiv wirken, indem sie die BBB-Transportfunktion über den MFSD2A/Cav-1-Signalweg verbessern.

Kernaussagen

  • Rattenmodell mit MCAO/R und zwei Wirkstoffgruppen
  • Bessere neurologische Werte, kleinere Infarktfläche, weniger Albuminleckage
  • MFSD2A und SREBP1 erhöht, Cav-1 vermindert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 20.01.2026. Verfasst von Peiru Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study compares the brain protective effects of L-borneolum and its main components (a combined application of L-borneol and L-camphor) on the rat model of middle cerebral artery occlusion/reperfusion (MCAO/R). It also makes clear the intrinsic regulatory mechanisms that link the neuroprotective effects of these compounds on IS to the blood-brain barrier (BBB), based on network pharmacology predictions. Furthermore, the study investigates the relationship between these compounds and the Major Facilitator Superfamily Domain-containing Protein 2A (MFSD2A)/Caveolin-1 (Cav-1) signaling axis.

Methods

The MCAO/R model in rats was established to evaluate the therapeutic effect of L-borneolum (200 mg/kg) and its main components combination of L-borneol and L-camphor (6:4 ratio, 200 mg/kg). Neurological scores, 2,3,5-triphenyl tetrazolium chloride (TTC) staining, hematoxylin-eosin (HE) staining, and Nissl staining were performed to evaluate the neurological damage in the rats. Cerebral blood flow Doppler was applied to monitor the cerebral blood flow changes. Immunofluorescence analysis of albumin leakage and transmission electron microscopy (TEM) were conducted to evaluate blood-brain barrier (BBB) integrity. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine the optimal drug concentration. Trans-epithelial electrical resistance (TEER) and horseradish peroxidase (HRP) assays were employed to confirm the successful establishment of an in vitro BBB co-culture model. Network pharmacology was utilized to predict the biological processes, molecular functions, and cellular components involved in the treatment of ischemic stroke (IS) by the main components of L-borneolum (L-borneol and L-camphor). Finally, immunofluorescence, real-time fluorescent quantitative PCR (RT-qPCR) and western blot analyses were performed to detect the expression of Major Facilitator Superfamily Domain Containing 2A (MFSD2A), caveolin-1 (CAV-1), sterol regulatory element-binding protein 1 (SREBP1) in brain tissue and hCMEC/D3 cells.

Results

Network pharmacology prediction indicated that L-borneolum and its main components (L-borneol and L-camphor) in the treatment of IS are likely associated with vesicle transport and neuroprotection. Treatment of IS with L-borneolum and its main components significantly decreased neurological function scores and cerebral infarction area, while alleviating pathological morphological changes and increasing the number of Nissl bodies in the hippocampus. Additionally, it improved cerebral blood flow, reduced albumin leakage, and decreased vesicle counts in the brain. The trans-epithelial electrical resistance (TEER) of the co-culture model stabilized on the fifth day after co-culture, and the permeability to horseradish peroxidase (HRP) in the co-culture model was significantly lower than that of the blank chamber at this time. RT-qPCR and Western blot results demonstrated that, compared to the model group, the expression of SREBP1 and MFSD2A significantly increased, while the expression of Cav-1 decreased.

Conclusions

L-borneolum and its main components combination (L-borneol/L-camphor, 6:4 ratio) may exert a protective effect in rats with IS by improving BBB transport function through modulation of the MFSD2A/Cav-1 signaling pathway.

Schlagwörter

Stichwörter der Autor:innen

L-borneol and L-camphorL-borneolumMFSD2A/Cav-1 signaling pathwayblood-brain barrierischemic stroke

Autor:innen und Institutionen

  • College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China.

ORCID-Profile: Yilun Ma

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, P., Ma, Y., Lu, D., Wen, L., Huang, F., Lian, J., Zhang, M., & Dong, T. (2026). L-Borneolum Attenuates Ischemic Stroke Through Remodeling BBB Transporter Function via Regulating MFSD2A/Cav-1 Signaling Pathway. Brain Sciences, 16(1), 111. https://doi.org/10.3390/brainsci16010111

Vancouver

Wang P, Ma Y, Lu D, Wen L, Huang F, Lian J, et al. L-Borneolum Attenuates Ischemic Stroke Through Remodeling BBB Transporter Function via Regulating MFSD2A/Cav-1 Signaling Pathway. Brain Sciences. 2026;16(1):111. doi:10.3390/brainsci16010111

BibTeX
@article{Wang2026,
  author = {Wang, Peiru and Ma, Yilun and Lu, Dazhong and Wen, Li and Huang, Fengyu and Lian, Jianing and Zhang, Mengmeng and Dong, Taiwei},
  title = {L-Borneolum Attenuates Ischemic Stroke Through Remodeling BBB Transporter Function via Regulating MFSD2A/Cav-1 Signaling Pathway},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {111},
  doi = {10.3390/brainsci16010111}
}
Kostenlos starten →